NIAID Banner Logo Image

Mycobacterium Citations List: April, 2020

Literature Citations

1. Design, Synthesis, and Biological Evaluation of Novel Arylcarboxamide Derivatives as Anti-tubercular Agents. Alsayed, S.S.R., S.C. Lun, G. Luna, C.C. Beh, A.D. Payne, N. Foster, W.R. Bishai, and H. Gunosewoyo. RSC Advances, 2020. 10(13): p. 7523-7540. ISI[000519586300017].
[WOS]. TB_04_2020.

2. In Vitro Inhibition of Mycobacterium tuberculosis beta-Carbonic anhydrase 3 with Mono- and Dithiocarbamates and Evaluation of their Toxicity Using Zebrafish Developing Embryos. Aspatwar, A., M. Hammaren, M. Parikka, S. Parkkila, F. Carta, M. Bozdag, D. Vullo, and C.T. Supuran. Journal of Enzyme Inhibition and Medicinal Chemistry, 2020. 35(1): p. 65-71. PMID[31663386]. [PMC6830242].
[PubMed]. TB_04_2020.

3. Antioxidant and Antibacterial Activity of Three Herbs Belonging to Zingiber Genus of Bangladesh. Aunjum, A., R. Biswas, T.R. Nurunnabi, S.M.M. Rahman, M.M. Billah, M.E. Islam, and K.M.D. Islam. Oriental Pharmacy and Experimental Medicine. 10: p. 7523-7540. ISI[000499104400001].
[WOS]. TB_04_2020.

4. Dimethylaminophenyl Hydrazides as Inhibitors of the Lipid Transport Protein LprG in Mycobacteria. Bai, L., L.A. Parkin, H. Zhang, R. Shum, M.L. Previti, and J.C. Seeliger. ACS Infectious Diseases, 2020. 6(4): p. 637-648. PMID[32053347].
[PubMed]. TB_04_2020.

5. Synthesis, Structure and Bioactivity of a Mononuclear Octahedral Prolinate(2)-Na(MeOH)(4) H--(+) Complex. Belveren, S., S. Poyraz, M. Ulger, C.M. Pask, H.A. Dondas, and J.M. Sansano. Inorganica Chimica Acta, 2020. 504. ISI[000514816900024].
[WOS]. TB_04_2020.

6. Antimicrobial Potential, Phytochemical Profile, Cytotoxic and Genotoxic Screening of Sedum praealtum A. DC. (Balsam). Boriollo, M.F.G., M.B. Marques, T.A. da Silva, J.J. da Silva, R.A. Dias, T.H.N. Silva Filho, I.L.R. Melo, C.T. Dos Santos Dias, W.L.C. Bernardo, N. de Mello Silva Oliveira, V.M. Peters, J.F. Hofling, and D.M.P. Spolidorio. BMC Complementary Medicine and Therapies, 2020. 20(133): 14pp. PMID[32349729]. PMCID[PMC7191818].
[PubMed]. TB_04_2020.

7. Design, Synthesis, and Evaluation of New 2-(Quinoline-4-yloxy)acetamide-based Antituberculosis Agents. Borsoi, A.F., J.D. Paz, B.L. Abbadi, F.S. Macchi, N. Sperotto, K. Pissinate, R.S. Rambo, A.S. Ramos, D. Machado, M. Viveiros, C.V. Bizarro, L.A. Basso, and P. Machado. European Journal of Medicinal Chemistry, 2020. 192: e112179. PMID[32113048].
[PubMed]. TB_04_2020.

8. Substituted N-(Pyrazin-2-yl)benzenesulfonamides; Synthesis, Anti-infective Evaluation, Cytotoxicity, and in Silico Studies. Bouz, G., M. Juhas, L.P. Otero, C.P. de la Red, O. Jan'ourek, K. Konecna, P. Paterova, V. Kubicek, J. Janousek, M. Dolezal, and J. Zitko. Molecules, 2020. 25(1): e138. PMID[31905775]. PMCID[PMC6982817].
[PubMed]. TB_04_2020.

9. Antituberculosis Activity of the Antimalaria Cytochrome bcc Oxidase Inhibitor SCR0911. Chong, S.M.S., M.S.S. Manimekalai, J.P. Sarathy, Z.C. Williams, L.K. Harold, G.M. Cook, T. Dick, K. Pethe, R.W. Bates, and G. Grüber. ACS Infectious Diseases, 2020. 6(4): p. 725-737. PMID[32092260].
[PubMed]. TB_04_2020.

10. New Amide Linked Dimeric 1,2,3-Triazoles Bearing Aryloxy Scaffolds as a Potent Antiproliferative Agents and EGFR Tyrosine Kinase Phosphorylation Inhibitors. Deshmukh, T.R., A.P. Sarkate, D.K. Lokwani, S.V. Tiwari, R. Azad, and B.B. Shingate. Bioorganic & Medicinal Chemistry Letters, 2019. 29(19): e126618. PMID[31431361].
[PubMed]. TB_04_2020.

11. Synthesis of Disulfide-bridged N-Phenyl-N'-(alkyl/aryl/heteroaryl)urea Derivatives and Evaluation of their Antimicrobial Activities. Dilem Doğan, Ş., S. Buran, M. Gözde Gündüz, C. Özkul, V. Siva Krishna, and D. Sriram. Chemistry and Biodiversity, 2019. 16(12): e1900461. PMID[31557406].
[PubMed]. TB_04_2020.

12. Targeting NAD-dependent Dehydrogenases in Drug Discovery against Infectious Diseases and Cancer. Ferraris, D.M., E.L.M. Gelardi, S. Garavaglia, R. Miggiano, and M. Rizzi. Biochemical Society Transactions, 2020. 48(2): p. 693-707. PMID[32311017].
[PubMed]. TB_04_2020.

13. Synthesis and Biological Evaluation of Theophylline acetohydrazide hydrazone Derivatives as Antituberculosis Agents. Gopinatha, V.K., Dukanya, K. Mantelingu, and K.S. Rangappa. Journal of the Chinese Chemical Society. ISI[000521817600001].
[WOS]. TB_04_2020.

14. Rifamycin O, an Alternative anti-Mycobacterium abscessus Agent. Hanh, B.T.B., J.W. Park, T.H. Kim, J.S. Kim, C.S. Yang, K. Jang, J. Cui, D.C. Oh, and J. Jang. Molecules, 2020. 25(7): e1597. PMID[32244387]. PMCID[PMC7181020].
[PubMed]. TB_04_2020.

15. Structural Investigation of Methyl 3-(4-fluoro-benzo-yl)-7-methyl-2-phenyl-indolizine-1-carboxyl-ate, an Inhibitory Drug Towards Mycobacterium tuberculosis. Hasija, A., S. Bhandary, K.N. Venugopala, S. Chandrashekharappa, and D. Chopra. Acta Crystallographica Section E: Crystallographic Communications, 2020. 76(Pt 4): p. 567-571. PMID[32280505]. PMCID[PMC7133047].
[PubMed]. TB_04_2020.

16. Dihydrofolate reductase Inhibitors for Use as Antimicrobial Agents. He, J., W. Qiao, Q. An, T. Yang, and Y. Luo. European Journal of Medicinal Chemistry, 2020. 195: e112268. PMID[32298876].
[PubMed]. TB_04_2020.

17. Preparation and Antitubercular Activities of Palindromic Hydrazinecar-bothioamides and Carbonothioic dihydrazides. Hearn, M.J., G. Towers, and M.H. Cynamon. Letters in Drug Design & Discovery, 2019. 16(11): p. 1202-1210. ISI[000492690000003].
[WOS]. TB_04_2020.

18. Design, Synthesis, Biological Evaluation and Molecular Dynamic Simulation Studies of Diphenyl ether Derivatives as Antitubercular and Antibacterial Agents. Khade, A.B., V.K. Eshwara, H.I.M. Boshoff, K. Arora, A. Tiwari, P. Bhat, M. Tiwari, and G.G. Shenoy. ChemistrySelect, 2020. 5(1): p. 201-210. PMID[WOS:000506438700027].
[WOS]. TB_04_2020.

19. Dual-target Inhibitors of Mycobacterial Aminoacyl-tRNA Synthetases among N-Benzylidene-N'-thiazol-2-yl-hydrazines. Kovalenko, O.P., G.P. Volynets, M.Y. Rybak, S.A. Starosyla, O.I. Gudzera, S.S. Lukashov, V.G. Bdzhola, S.M. Yarmoluk, H.I. Boshoff, and M.A. Tukalo. MedcChemComm, 2019. 10(12): p. 2161-2169. PMID[32206244]. PMCID[PMC7069510].
[PubMed]. TB_04_2020.

20. Design and Development of ((4-Methoxyphenyl)carbamoyl) (5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazol-2-yl)amide Analogues as Mycobacterium tuberculosis Ketol-acid reductoisomerase Inhibitors. Krishna, V.S., S. Zheng, E.M. Rekha, R. Nallangi, D.V. Sai Prasad, S.E. George, L.W. Guddat, and D. Sriram. European Journal of Medicinal Chemistry, 2020. 193: e112178. PMID[32171154].
[PubMed]. TB_04_2020.

21. Polyketide-derived Secondary Metabolites from a Dothideomycetes Fungus, Pseudopalawania siamensis gen. et sp. nov., (Muyocopronales) with Antimicrobial and Cytotoxic Activities. Mapook, A., A.P.G. Macabeo, B. Thongbai, K.D. Hyde, and M. Stadler. Biomolecules, 2020. 10(4): e569. PMID[32276418].
[PubMed]. TB_04_2020.

22. 5-Chloro-2-thiophenyl-1,2,3-triazolylmethyldihydroquinolines as Dual Inhibitors of Mycobacterium tuberculosis and Influenza Virus: Synthesis and Evaluation. Marvadi, S.K., V.S. Krishna, E.O. Sinegubova, A.S. Volobueva, Y.L. Esaulkova, A.A. Muryleva, D.G. Tentler, D. Sriram, V.V. Zarubaev, and S. Kantevari. Bioorganic & Medicinal Chemistry Letters, 2019. 29(18): p. 2664-2669. PMID[31375291].
[PubMed]. TB_04_2020.

23. Recursive Partitioning Analysis and Anti-tubercular Screening of 3-Aminopyrazine-2-carbohydrazide Derivatives. Miniyar, P., A. Mahajan, D. Anuse, A. Kumar, M. Barmade, D. Sarkar, M. Arkile, and V. Khedkar. Letters in Drug Design & Discovery, 2019. 16(11): p. 1264-1275. ISI[000492690000008].
[WOS]. TB_04_2020.

24. Synthesis, Molecular Docking, Antimicrobial Evaluation, and DNA Cleavage Assay of New Thiadiazole/Oxadiazole Ciprofloxacin Derivatives. Mohammed, H.H.H., S.H. Abbas, E.M.N. Abdelhafez, J.M. Berger, S. Mitarai, M. Arai, and G. Abuo-Rahma. Monatshefte fur Chemie, 2019. 150(10): p. 1809-1824. ISI[000514591400011].
[WOS]. TB_04_2020.

25. Ziziphus mucronata Willd. (Rhamnaceae): It's Botany, Toxicity, Phytochemistry and Pharmacological Activities. Mongalo, N.I., S.S. Mashele, and T.J. Makhafola. Heliyon, 2020. 6(4): e03708. PMID[32322712]. PMCID[PMC7170964].
[PubMed]. TB_04_2020.

26. Synthesis, Characterization and Sem Studies of Novel 1-Indanyl Isoniazid and Hydrazide Schiff Base Derivatives as New Anti-tubercular Agents. Nazim, U., S.I. Ali, G. Ishrat, A. Hassan, M. Ahmed, M. Ali, Z. Ali, and M.Y. Noori. Pakistan Journal of Pharmaceutical Sciences, 2020. 33(3): p. 1095-1103. ISI[000523571000024].
[WOS]. TB_04_2020.

27. Antibacterial Activity of Cissus incisa Extracts against Multidrug-resistant Bacteria. Nocedo-Mena, D., E. Garza-González, M. González-Ferrara, and M. Del Rayo Camacho-Corona. Current Topics in Medicinal Chemistry, 2020. 20(4): p. 318-323. PMID[31755390].
[PubMed]. TB_04_2020.

28. Antibacterial and Antimycobacterial Activity of Crude Extracts, Fractions, and Isolated Compounds from Leaves of Sneezewood, Ptaeroxylon obliquum (Rutaceae). Ramadwa, T.E., M.D. Awouafack, M.S. Sonopo, and J.N. Eloff. Natural Product Communications, 2019. 14(9): 7pp. ISI[000498005000002].
[WOS]. TB_04_2020.

29. Synergistic Interactions of Indole-2-carboxamides and beta-Lactam Antibiotics against Mycobacterium abscessus. Raynaud, C., W. Daher, F. Roquet-Baneres, M.D. Johansen, J. Stec, O.K. Onajole, D. Ordway, A.P. Kozikowski, and L. Kremer. Antimicrobial Agents and Chemotherapy, 2020. 64(5). PMID[32041716]. PMCID[PMC7179587].
[PubMed]. TB_04_2020.

30. First Triclosan-based Macrocyclic Inhibitors of InhA Enzyme. Rodriguez, F., N. Saffon, J.C. Sammartino, G. Degiacomi, M.R. Pasca, and C. Lherbet. Bioorganic Chemistry, 2020. 95: e103498. PMID[31855823].
[PubMed]. TB_04_2020.

31. A New Citrinin Derivative from the Indonesian Marine Sponge-associated Fungus Penicillium citrinum. Sabdaningsih, A., Y. Liu, U. Mettal, J. Heep, Riyanti, L. Wang, O. Cristianawati, H. Nuryadi, M. Triandala Sibero, M. Marner, O.K. Radjasa, A. Sabdono, A. Trianto, and T.F. Schaberle. Marine Drugs, 2020. 18(4): e227. PMID[32344725].
[PubMed]. TB_04_2020.

32. 1,3-Oxazole-Isoniazid Hybrids: Synthesis, Antitubercular Activity, and their Docking Studies. Shah, S.R. and K.D. Katariya. Journal of Heterocyclic Chemistry, 2020. 15(4): p. 1682-1691. ISI[000507642400001].
[WOS]. TB_04_2020.

33. Synthesis and Antimycobacterial Activity of Disubstituted Benzyltriazoles. Smit, F.J., R. Seldon, J. Aucamp, A. Jordaan, D.F. Warner, and D.D. N'Da. Medicinal Chemistry Research, 2019. 28(12): p. 2279-2293. ISI[000492179700001].
[WOS]. TB_04_2020.

34. Enhanced Bactericidal Effects of Pyrazinamide toward Mycobacterium smegmatis and Mycobacterium tuberculosis Upon Conjugation to a {Au(I)-triphenylphosphine}(+) Moiety. Stenger-Smith, J., M. Kamariza, I. Chakraborty, R. Ouattara, C.R. Bertozzi, and P.K. Mascharak. ACS Omega, 2020. 5(12): p. 6826-6833. PMID[32258918]. PMCID[PMC7114878].
[PubMed]. TB_04_2020.

35. Synthesis, Evaluation, Molecular Docking, and Molecular Dynamics Studies of Novel N-(4-[Pyridin-2-yloxy]benzyl)arylamine Derivatives as Potential Antitubercular Agents. Verma, R., H.I.M. Boshoff, K. Arora, I. Bairy, M. Tiwari, B.G. Varadaraj, and G.G. Shenoy. Drug Development Research, 2019. 81(3): p. 315-328. PMID[31782209].
[PubMed]. TB_04_2020.

36. Design, Synthesis and in Vitro Controlled Release of New Adamantanodiarylketone Antimycobacterials. Vlachou, M., I.P. Papanastasiou, M.O. Georgiadis, A. Tsakoumagkou, Z. Siskos, A. Siamidi, A. Konstantinou, A. Vocat, and S.T. Cole. ChemistrySelect, 2019. 4(37): p. 11048-11051. ISI[000492439600012].
[WOS]. TB_04_2020.

37. Identification of Novel DHFR Inhibitors for Treatment of Tuberculosis by Combining Virtual Screening with in Vitro Activity Assay. Wang, N., J.X. Ren, and Y. Xie. Journal of Biomolecular Structure and Dynamics, 2019. 37(4): p. 1054-1061. PMID[29504455].
[PubMed]. TB_04_2020.

38. Selective Phenylimidazole-based Inhibitors of the Mycobacterium tuberculosis Proteasome. Zhan, W., H.C. Hsu, T. Morgan, T. Ouellette, K. Burns-Huang, R. Hara, A.G. Wright, T. Imaeda, R. Okamoto, K. Sato, M. Michino, M. Ramjee, K. Aso, P.T. Meinke, M. Foley, C.F. Nathan, H. Li, and G. Lin. Journal of Medicinal Chemistry, 2019. 62(20): p. 9246-9253. PMID[31560200]. PMCID[PMC7091493].
[PubMed]. TB_04_2020.

Patent Citations

39. Compounds with Copper- or Zinc-Activated Toxicity against Microbial Infection. Bossmann, S.H., M. Kalubowilage, M. Zhang, A. Delpe-Acharige, K. Eschliman, F. Wolschendorf, O. Kutsch, A. Dalecki, and W. Narmore. Patent. 2020. 2019-US52087 2020061412: 74pp.
[Patent]. TB_04_2020.

40. Preparation of Antituberculosis Lanostane Triterpenoids. Isaka, M., P. Chinthanom, V. Vichai, K. Dokladda, M. Sappan, and C. Thongpanchang. Patent. 2020. 2019-TH37 2020068004: 40pp.
[Patent]. TB_04_2020.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: May 2020